Avelumab for Advanced Merkel Cell Carcinoma: Global Real-World Data on Patient Response and Survival.

Lohray, Rishabh; Verma, Kritin K; Wang, Leo L; Haynes, Dylan; Lewis, Daniel J

Lohray, Rishabh; Verma, Kritin K; Wang, Leo L; Haynes, Dylan; Lewis, Daniel J.

Afiliação

Lohray R; Baylor College of Medicine, Houston, TX, USA.
Verma KK; Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX, USA.
Wang LL; Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.
Haynes D; Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.
Lewis DJ; Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.

Pragmat Obs Res ; 14: 149-154, 2023.

Article em En | MEDLINE | ID: mdl-38021416

Palavras-chave

Merkel cell carcinoma; adverse events; avelumab; immune-checkpoint inhibitors; real-world studies; tumor response

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pragmat Obs Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google